Tajikistan Receives Another Batch of Pfizer-BioNTech Vaccines
Read also
DUSHANBE, 16.12.2021 (NIAT Khovar) – Yesterday evening, 141,570 doses of Pfizer-BioNTech vaccines were delivered to Tajikistan at the initiative of the government as part of the COVAX mechanism, reports the Ministry of Health and Social Protection of the Population.
Earlier this week Tajikistan received 157,950 doses of Pfizer-BioNTech vaccines and 302,400 doses of AstraZeneca vaccines.
The vaccines have been introduced to prevent the spread of COVID-19 and to provide immunization to citizens.
As of December 15, 3,386,686 people or 58.1% have been vaccinated against COVID-19 in Tajikistan. More than 2.7 million or 47.3% have received both doses of the vaccine.
The immunization campaign against COVID-19 is ongoing in all areas of Tajikistan.
Lonely Planet Includes Tajikistan among the World’s Best Travel Experiences
Emomali Rahmon and Xi Jinping Highlight Significance of Launching Direct Passenger Flights between Dushanbe and Beijing
Tajikistan Provides Key Platform for Science–Policy Dialogue on Glacier Preservation, Says UCA Researcher
CGTN Journalist Praises Tajikistan’s Leadership on Glaciers’ Issues and Highlights China-Tajikistan Cooperation
UN Women Official Stresses the Role of Women in Climate Action at Glaciers’ Conference in Dushanbe
Japanese Researcher Highlights Tajikistan’s Role in Regional Water Security at High-Level Glaciers’ Conference
“This is Not Just Ice – This is Life”: UN Deputy Chief Calls for Urgent Action at Glaciers Conference in Dushanbe
Dushanbe Hosts Landmark International High-Level Conference on Glaciers’ Preservation
The Climate Crisis Is Primarily a Crisis of Children’s Rights
Chinese Scientist Highlights Glacier Retreat as a Tangible Reality for Tajikistan, the Region, and the World
Dushanbe Conference Launches New Era in Global Glacier Diplomacy
Global Leaders Urged to Fund UN Trust for Glacier Preservation
